天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

(5S,8S,9S,10S,13S,14S,17S)-17-hydroxy-10,13-dimethyl-4,5,6,7,8,9,11,12 ,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-2-carbaldehyde

(5S,8S,9S,10S,13S,14S,17S)-17-hydroxy-10,13-dimethyl-4,5,6,7,8,9,11,12 ,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-2-carbaldehyde Struktur
601-16-1
CAS-Nr.
601-16-1
Englisch Name:
(5S,8S,9S,10S,13S,14S,17S)-17-hydroxy-10,13-dimethyl-4,5,6,7,8,9,11,12 ,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-2-carbaldehyde
Synonyma:
17beta-Hydroxy-5alpha-androst-2-ene-2-carboxaldehyde;Androst-2-ene-2-carboxaldehyde, 17-hydroxy-, (5α,17β)-;(5S,8S,9S,10S,13S,14S,17S)-17-hydroxy-10,13-dimethyl-4,5,6,7,8,9,11,12 ,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-2-carbaldehyde
CBNumber:
CB01260869
Summenformel:
C20H30O2
Molgewicht:
302.45
MOL-Datei:
601-16-1.mol

(5S,8S,9S,10S,13S,14S,17S)-17-hydroxy-10,13-dimethyl-4,5,6,7,8,9,11,12 ,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-2-carbaldehyde Eigenschaften

Sicherheit

(5S,8S,9S,10S,13S,14S,17S)-17-hydroxy-10,13-dimethyl-4,5,6,7,8,9,11,12 ,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-2-carbaldehyde Chemische Eigenschaften,Einsatz,Produktion Methoden

(5S,8S,9S,10S,13S,14S,17S)-17-hydroxy-10,13-dimethyl-4,5,6,7,8,9,11,12 ,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-2-carbaldehyde Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

(5S,8S,9S,10S,13S,14S,17S)-17-hydroxy-10,13-dimethyl-4,5,6,7,8,9,11,12 ,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-2-carbaldehyde Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Global( 0)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
  • (5S,8S,9S,10S,13S,14S,17S)-17-hydroxy-10,13-dimethyl-4,5,6,7,8,9,11,12 ,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-2-carbaldehyde
  • 17beta-Hydroxy-5alpha-androst-2-ene-2-carboxaldehyde
  • Androst-2-ene-2-carboxaldehyde, 17-hydroxy-, (5α,17β)-
  • 601-16-1
Copyright 2019 ? ChemicalBook. All rights reserved